Share Price: Sweden

Share Price: US

*ADS listed in USD at Nasdag US. One ADS represent two common shares.

Interim Report Q1 2022

On May 18, 2022, at 07:00 CEST, Calliditas Therapeutics published its interim report for the first quarter 2022.

Audio cast with teleconference, Q1 2022, May 18, 2022, 14:30 CET

• Report
• Presentation
• Webcast

Read the report

IR Calendar

• Aug 18, 2022Interim report for the period January 1 – June 30, 2022
• Nov 17, 2022Interim report for the period January 1 – September 30, 2022
• Feb 23, 2023Year-end report for the period January 1 – December 31, 2022

All events